WRX-19744-02942 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-30
Dose 1 — Pfizer-BioNTech
2021-04-27
Dose 2 — Pfizer-BioNTech
2022-01-08
Dose 3 — Pfizer-BioNTech
2022-03-02
Registered in v-safe
2022-04-09
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-07-09
Survey response — 6 months, dose 3
MedDRA: Menstruation delayed — Feeling: Good

Free text: Delayed menstrual cycle

MedDRA releases: 2024-11 · check-in free text available
2023-01-08
Survey response — 12 months, dose 3
MedDRA: Acne, Menstruation irregular — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-01-08
Report sent to call center — 12 months, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-01-09
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-30	Pfizer-BioNTech	No
2	2021-04-27	Pfizer-BioNTech	No
3	2022-01-08	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2023-01-08	Unsuccessful

Free text

Release 12 — 6 months, dose 3

2022-07-09

Symptoms: Delayed menstrual cycle

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Acne	·	·	✓
SD	Menstruation delayed	·	·	✓
SD	Menstruation irregular	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release